FDA Investigator Hung H Do, MS

Hung H Do, MS has conducted inspections on 21 sites in 4 countries as of 29 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
21
Last Inspection Date:
29 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
100006750
Countries of Inspections:
United States of America, China, Belgium, Germany
FDA Investigators that have inspected at least one site in common with Hung H Do, MS:
Alicia M Mozzachio, Anderson, Andrew Le, Andrew W Harmon, Angel K Sandhu, Anh M Lac, Anita Narula, PhD, Ashar P Parikh, Binh T Nguyen, Brent W Higgs, Bryan A Galvez, Candace Y Gomez Broughton, Carl Lee, Carla J Lundi, Carolyn A Renshaw, Carrie A Hughes, Cathleen A Carr Sharpe, CDR Rochelle B Young, RPh, MSA, CDR Thomas R Berry, PPh, Charisse K Green, Cheryl D Mccall, Chiaochun J Wang, Christin L Torres, Christopher R Czajka, Courtney R Ingalsbe, Crystal Monroy, Darren S Brown, David P Vanhouten, Deborah W Hsu, Diana L Ayala, Diana M Rand, Diane Cvan Leeuwen, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Eileen A Liu, Emmanuel Adu Gyamfi, PhD, George Lunn, PhD, Ginger M Sykes, Gloria J Baca, MS, Heidy C Perales, Helen B Ricalde, Henry K Lau, Huiquan Wu, Jai P Singh, James P Stallings, James R Fleckenstein, Jamie L Dion, Jeffrey M Watson, Jinnie Kokiatkulkij, Jocelyn E Massey, Joey V Quitania, John A Gonzalez, Jolanna A Norton, Jonathan G Matrisciano, Joslyn K Brunelle, PhD, Judy C Nepsa, Junho Pak, Katherine E Jacobitz, Kelley, Kevin N Tran, Kevin P Foley, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Ko U Min, Kristin M Abaonza, Kula N Jha, Lance A Finnical, Lance Mde Souza, MBA, Lanita F Kelley, Laura Fontan, MS, Lavender M Huskey, Liming Zhang, Linda Thai, Lisa K Capron, Marcellinus D Dordunoo, Marcus F Yambot, Marijo B Kambere, PhD, Marion W Nadeau, Michael D Garcia, Minh D Phan, Nataniel Phillips Sylvain, PhD, Nathan R Moon, Nicholas L Hunt, Patrick C Klotzbuecher, Paula A Trost, Prabhu P Raju, Randall N Johnson, Raymond T Oji, Richmond K Yip, Robert D Tollefsen, Rochelle L Cross, Rowena S Nguyen, Rumany C Penn, PharmD, Saied A Asbagh, Sandra A Hughes, Sarah A Hassas, Sherri J Jackson, Sonya L Karsik, RAC, Sridhar Thumma, Steven D Kehoe, Steven E Porter, Jr, Sundy V Sedwick, Susan F Laska, MS, Susan W Ting, Thomas J Arista, Thomas R Withers, Timothy T Kapsala, Tracey L Harris, Tracy K Li, Uduak M Inokon, Uttaniti Limchumroon (Tom), Vashti E Bocker, Victoria A Wagoner, Wenzheng Wendy Zhang, William J Leonard, William V Millar, Yasamin Ameri, Ying Xin Fan, PhD, Yiyue Zhang (nmi), PhD, Zachary A Bogorad

Hung H Do, MS's Documents

Publish Date Document Type Title
May, 2023 FDA 483 Lonza Bend Inc. - Form 483, 2023-05-24
April, 2021 EIR BioMarin Pharmaceutical Inc. - EIR, 2021-04-02
April, 2021 FDA 483 Response BioMarin Pharmaceutical Inc. - Form 483R, 2021-04-02
November, 2023 FDA 483 AnuMed International LLC - Form 483, 2023-11-07
March, 2023 FDA 483 COSMOBEAUTI LABORATORIES & MANUFACTURING, INC. - Form 483, 2023-03-15
November, 2022 FDA 483 Deseret Laboratories, Inc. - Form 483, 2022-11-18
April, 2021 FDA 483 BioMarin Pharmaceutical Inc. - Form 483, 2021-04-02
May, 2022 FDA 483 Omya Inc. - Form 483, 2022-05-27
August, 2022 FDA 483 Clean Cosmetics, LLC - Form 483, 2022-08-19
June, 2021 FDA 483 Sanitor Corporation - Form 483, 2021-06-03
March, 2022 FDA 483 Dr. J SkinClinic, Inc. - Form 483, 2022-03-17
December, 2023 FDA 483 Xiamen Tiger Medical Company, Ltd - Form 483, 2023-12-19
December, 2023 FDA 483 Landy International - Form 483, 2023-12-14
July, 2024 FDA 483 ASPHAR RESEARCH LABS PRIVATE LIMITED - Form 483, 2024-07-17
April, 2024 FDA 483 Estee Lauder N.V. - Form 483, 2024-04-26
May, 2025 FDA 483 Voyant Beauty, Inc. - Form 483, 2025-05-30
December, 2023 FDA 483 GFA Production (Xiamen) Co., Ltd. - Form 483, 2023-12-08
May, 2025 FDA 483 SV Labs Toronto Corporation - Form 483, 2025-05-23
February, 2025 FDA 483 JIANGSU TIANHE PHARMACEUTICAL CO., LTD. - Form 483, 2025-02-28
September, 2025 FDA 483 LUPIN LIMITED - Form 483, 2025-09-16
March, 2025 FDA 483 Taizhou Kangping Medical Science And Technology Co., Ltd. - Form 483, 2025-03-14

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more